← All trials
NCT03995017
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 31, 2019
- Primary completion
- May 31, 2021
- Completion date
- Jul 31, 2024
- First posted
- —
- Last posted
- —
- Enrollment
- 61
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of KansasLead sponsor
- Clovis OncologyCollaborator
- University of KansasOverall official - principal investigator
- Bristol-Myers SquibbCollaborator
- University of KansasOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.